Our analysis showed that MYC mRNA expression was significantly higher in patients with MYC amplification compared to those without, highlighting MYC as one of the frequently amplified genes in HNSCC (Figure 2B). This evidence concerns the gene MYC and head and neck squamous cell carcinoma.